These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 2403488)

  • 21. Experimental chemotherapy and concepts related to the cell cycle.
    Tannock IF
    Int J Radiat Biol Relat Stud Phys Chem Med; 1986 Feb; 49(2):335-55. PubMed ID: 3510996
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Solitary cancer cells as a possible source of tumour dormancy?
    Naumov GN; MacDonald IC; Chambers AF; Groom AC
    Semin Cancer Biol; 2001 Aug; 11(4):271-6. PubMed ID: 11513562
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Critical determinants of metastasis.
    Fidler IJ
    Semin Cancer Biol; 2002 Apr; 12(2):89-96. PubMed ID: 12027580
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dormant Circulating Tumor Cells in Prostate Cancer: Therapeutic, Clinical and Biological Implications.
    Alvarez-Cubero MJ; Vázquez-Alonso F; Puche-Sanz I; Ortega FG; Martin-Prieto M; Garcia-Puche JL; Pascual-Geler M; Lorente JA; Cozar-Olmo JM; Serrano MJ
    Curr Drug Targets; 2016; 17(6):693-701. PubMed ID: 25751007
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Theories on the metastatic process and possible therapeutic options.
    Effert PJ; Strohmeyer TG
    Urol Res; 1995; 23(1):11-9. PubMed ID: 7618230
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Highly Concordant Key Genetic Alterations in Primary Tumors and Matched Distant Metastases in Differentiated Thyroid Cancer.
    Sohn SY; Park WY; Shin HT; Bae JS; Ki CS; Oh YL; Kim SW; Chung JH
    Thyroid; 2016 May; 26(5):672-82. PubMed ID: 26971368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Tumor cell dormancy: implications for the biology and treatment of breast cancer.
    Fehm T; Mueller V; Marches R; Klein G; Gueckel B; Neubauer H; Solomayer E; Becker S
    APMIS; 2008; 116(7-8):742-53. PubMed ID: 18834416
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epithelial-mesenchymal plasticity is a decisive feature for the metastatic outgrowth of disseminated WAP-T mouse mammary carcinoma cells.
    Maenz C; Lenfert E; Pantel K; Schumacher U; Deppert W; Wegwitz F
    BMC Cancer; 2015 Mar; 15():178. PubMed ID: 25886487
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multidrug resistance and behavioural phenotype of cancer cells.
    Bashir I; Sikora K; Foster CS
    Cell Biol Int; 1993 Oct; 17(10):907-17. PubMed ID: 8287021
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.
    Kauffman EC; Robinson VL; Stadler WM; Sokoloff MH; Rinker-Schaeffer CW
    J Urol; 2003 Mar; 169(3):1122-33. PubMed ID: 12576866
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mutational status of synchronous and metachronous tumor samples in patients with metastatic non-small-cell lung cancer.
    Quéré G; Descourt R; Robinet G; Autret S; Raguenes O; Fercot B; Alemany P; Uguen A; Férec C; Quintin-Roué I; Le Gac G
    BMC Cancer; 2016 Mar; 16():210. PubMed ID: 26968843
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cell dormancy and tumor refractory.
    Wang K; Jiang W; Cheng C; Li Y; Tu M
    Anticancer Agents Med Chem; 2013 Feb; 13(2):1312-1316. PubMed ID: 22934702
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Persistence of solitary mammary carcinoma cells in a secondary site: a possible contributor to dormancy.
    Naumov GN; MacDonald IC; Weinmeister PM; Kerkvliet N; Nadkarni KV; Wilson SM; Morris VL; Groom AC; Chambers AF
    Cancer Res; 2002 Apr; 62(7):2162-8. PubMed ID: 11929839
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic Heterogeneity in Therapy-Naïve Synchronous Primary Breast Cancers and Their Metastases.
    Ng CKY; Bidard FC; Piscuoglio S; Geyer FC; Lim RS; de Bruijn I; Shen R; Pareja F; Berman SH; Wang L; Pierga JY; Vincent-Salomon A; Viale A; Norton L; Sigal B; Weigelt B; Cottu P; Reis-Filho JS
    Clin Cancer Res; 2017 Aug; 23(15):4402-4415. PubMed ID: 28351929
    [No Abstract]   [Full Text] [Related]  

  • 36. Generation of metastatic variants by transfection of a nonmetastatic rat mammary epithelial cell line with DNA from a metastatic rat mammary cell line.
    Jamieson S; Barraclough R; Rudland PS
    Pathobiology; 1990; 58(6):329-42. PubMed ID: 2078312
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Differential diagnosis of ovarian metastases].
    Hauptmann S
    Pathologe; 2007 May; 28(3):215-21. PubMed ID: 17393169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Suppression of Metastasis by Primary Tumor and Acceleration of Metastasis Following Primary Tumor Resection: A Natural Law?
    Hanin L; Rose J
    Bull Math Biol; 2018 Mar; 80(3):519-539. PubMed ID: 29302774
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Chromosomal aberrations related to metastasis of human solid tumors.
    Qin LX
    World J Gastroenterol; 2002 Oct; 8(5):769-76. PubMed ID: 12378613
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Taurolidine improves survival by abrogating the accelerated development and proliferation of solid tumors and development of organ metastases from circulating tumor cells released following surgery.
    Da Costa ML; Redmond HP; Bouchier-Hayes DJ
    J Surg Res; 2001 Dec; 101(2):111-9. PubMed ID: 11735264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.